Pesquisar neste blogue

25 maio 2020

OurRisk.CoV | COVID-19 Phenomics: We recently used large-scale samples of NHS patient data to estimate the excess risk of mortality which may be associated with coronavirus (COVID-19). We wanted to develop this research to inform simple tools to allow interaction and exploration by policymakers, researchers and the public.
In the OurRisk.CoV tool, we provide our initial learning in relation to the implementation and development of policy responses to the COVID-19 pandemic.
We have provided some simple tools to allow interaction and exploration.
Etiquetas:
  • The Value of a Cure: An Asset Pricing Perspective
    The Value of a Cure: An Asset Pricing Perspective : We provide an estimate of the value of a cure using the joint behavior of stock prices ...
  • The Oxford/AstraZeneca Vaccine Efficacy Data
    The Oxford/AstraZeneca Vaccine Efficacy Data : We’re going to have to wait and collect more data to be able to say anything about these, fo...
  • (sem nome)
    A flood of coronavirus apps are tracking us. Now it’s time to keep track of them. So far we have documented 25 individual, significant auto...